Literature DB >> 10073415

Evaluation of ELVIS HSV ID/Typing System for the detection and typing of herpes simplex virus from clinical specimens.

B M Turchek1, Y T Huang.   

Abstract

BACKGROUND: Herpes simplex virus (HSV) is a common pathogen with two serotypes: HSV-1 and HSV-2. HSV infection does not pose much of a threat to an immunocompetent host but to an immunocompromised host or a neonate the infection can be fatal. The Enzyme-Linked Virus Inducible System (ELVIS) employs a genetically altered baby hamster kidney (BHK) cell line that allows for the rapid overnight detection of HSV but also includes an immunofluorescent stain for the simultaneous detection and typing of HSV-1 and HSV-2.
OBJECTIVE: To evaluate the ELVIS HSV ID/Typing System in comparison with HSV identification and typing in primary rabbit kidney (PRK) cells grown in shell vials. STUDY
DESIGN: Over a period of 6 weeks, 130 specimens were submitted to the diagnostic virology laboratory and cultured for the presence of HSV. Two PRK shell vials and one ELVIS BHK shell vial were inoculated with patient specimen. PRK shell vials were observed for cytopathic effect (CPE) for up to 4 days. When CPE was observed the PRK shell vials were fixed and one shell vial was stained with HSV-1 monoclonal antibody (Mab) and the other was stained with HSV-2 Mab. The coverslips were observed under the fluorescent microscope for specific apple-green fluorescence. The BHK shell vials were incubated overnight, fixed, and stained with galactopyranoside (X-Gal). If blue cells were present, the specimen was positive for HSV. The coverslip was then observed under the fluorescent microscope for the presence of specific apple-green fluorescence, indicating HSV-2. If no specific apple-green stain was observed, the coverslip was stained with a fluorescent conjugated goat anti-mouse IgG to determine the presence of HSV-1.
RESULTS: Of the 130 specimens, PRK shell vials detected 43 positive HSV; 30 were HSV-2 and 13 were HSV-1. The ELVIS BHK shell vials detected 42 positive HSV; 30 were HSV-2 and 12 were HSV-1. One low titer specimen was not identified as being HSV positive. Two specimens were not directly typed by the ELVIS system. One specimen had only one blue cell present and did not show specific staining for either HSV-1 or HSV-2. The other specimen had only five blue cells present and only one fluorescent cell present that was difficult to type. As suggested by the manufacturer's instructions, both specimens that were not directly typed were re-grown overnight from their supernatants and were correctly identified and typed.
CONCLUSION: The ELVIS HSV ID/Typing System is a rapid, highly specific and sensitive method of overnight HSV detection and typing.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10073415     DOI: 10.1016/s0928-0197(98)00066-x

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  5 in total

1.  Cryopreserved cell monolayers for rapid detection of herpes simplex virus and influenza virus.

Authors:  Yung T Huang; Huimin Yan; Yan Sun; Joseph A Jollick; Heather Baird
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

2.  Herpes diagnostic tests and their use.

Authors:  Nicholas J Van Wagoner; Edward W Hook
Journal:  Curr Infect Dis Rep       Date:  2012-04       Impact factor: 3.725

Review 3.  Role of cell culture for virus detection in the age of technology.

Authors:  Diane S Leland; Christine C Ginocchio
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

Review 4.  Virological and Immunological Outcomes of Coinfections.

Authors:  Naveen Kumar; Shalini Sharma; Sanjay Barua; Bhupendra N Tripathi; Barry T Rouse
Journal:  Clin Microbiol Rev       Date:  2018-07-05       Impact factor: 26.132

Review 5.  Light microscopy, culture, molecular, and serologic methods for detection of herpes simplex virus.

Authors:  Neil W Anderson; Blake W Buchan; Nathan A Ledeboer
Journal:  J Clin Microbiol       Date:  2013-10-16       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.